L&S Research Corporation Proposed Consent Agreement (1994)

The FTC claimed that L&S Research claimed that its products were effective in achieving results that were not supported by reliable scientific research.


L&S Research Corporation manufactured weight loss and body building supplements marketed under the Cybergencis trade name. The company agreed to stop advertising that the product would be effective in helping the user gain muscle or lose fat and that the product would work for all users. The company also agreed to stop using before and after photographs in the marketing of their products unless the photographs represent the typical experience of the users and the photographs are true representations. The company further agreed to pay a fine of $1.45 million, and maintain records of their compliance with the consent agreement.

Full case and case summary are also available online at: http://www.mlmlegal.com/legal-cases/L&SResearchCorporationProposedConsentAgreement1994.php

LOADING PDF: If there are any problems, click here to download the file.

Reference Info:Federal, Federal Circuit | United States

DISCLAIMER: Because of the generality of this update, the information provided herein may not be applicable in all situations and should not be acted upon without specific legal advice based on particular situations.

© Babener & Associates | Attorney Advertising

Written by:


Babener & Associates on:

Readers' Choice 2017
Reporters on Deadline

"My best business intelligence, in one easy email…"

Your first step to building a free, personalized, morning email brief covering pertinent authors and topics on JD Supra:

Sign up to create your digest using LinkedIn*

*By using the service, you signify your acceptance of JD Supra's Privacy Policy.

Already signed up? Log in here

*With LinkedIn, you don't need to create a separate login to manage your free JD Supra account, and we can make suggestions based on your needs and interests. We will not post anything on LinkedIn in your name. Or, sign up using your email address.